semaglutide and cardiovascular New Science Suggests Improves CV Outcomes Beyond Weight Loss Semaglutide and the Vascular System

S.RyanT

Cell Physiol Biochem 16: 133146

Document what changed, when it started, and how it compares to your baseline mood

By the six-month mark, many Wegovy users have lost 5-10% of their starting body weight

doi: 10.3389/fimmu.2024.1464329 Received 13 July 2024 Accepted 17 September 2024 Published 07 October 2024 Volume 15 - 2024 Edited by Philip Calder, University of Southampton, United Kingdom Reviewed by Md Tajmul, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), United States Isaacson Bababode Adelani, Johns Hopkins Medicine, United States Updates Copyright 2024 Munteanu, Mrza and Papuc

Your thyroid function should be stable and well-controlled before starting Wegovy, and may need monitoring after significant weight loss